TLDR Most COVID-19 patients had lingering symptoms 60 days after leaving the hospital.
The study at an Italian tertiary care center followed 100 COVID-19 patients 60 days after hospital discharge, revealing that 84% experienced persistent symptoms, such as fatigue, dyspnea, and insomnia, with fatigue being the most common at 46%. Unusual symptoms like hair loss were reported by 8% of patients, with a noted link to male pattern baldness. The persistence of symptoms was not related to the initial severity of COVID-19, ICU admission, or hospital stay length, but older age increased the risk of symptom persistence. Additionally, 10% of patients were readmitted, often due to cardiac issues, and 19% experienced rectal colonization with multidrug-resistant bacteria. The study emphasized the importance of continued monitoring and care for recovering COVID-19 patients to address ongoing health issues and improve their quality of life.
134 citations
,
April 2020 in “Journal of Cosmetic Dermatology” Male pattern hair loss could hint at androgens affecting COVID-19 severity.
2 citations
,
January 1980 in “Acupuncture & electro-therapeutics research” Hair loss might be due to nerve issues, treatable with electric stimulation or acupuncture.
5 citations
,
January 2012 in “Dermatology” Adapted classification better assesses male pattern hair loss and its link to heart disease.
January 2024 in “Journal of Cosmetics, Dermatological Sciences and Applications” Injecting a peptide-hyaluronic acid mix improved hair growth in men with hair loss and was safe.
26 citations
,
October 2012 in “Dermatologic Clinics” The document details hair transplantation techniques and innovations, highlighting Follicular Unit Transplantation as the standard and discussing the effectiveness and challenges of the procedure.
32 citations
,
January 2018 in “American Journal of Clinical Dermatology” Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.
17 citations
,
January 2016 in “American Journal of Epidemiology” Men with male pattern baldness have a higher risk of dying from prostate cancer.
